Viewing nowSamsit Tablet 100 mg (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Samsung Pharm Co., Ltd.

MFDS item code 202004041 · Approved 2020.05.29 · Insurance code 642308460
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. Patients can take this medication along with dietary changes and exercise to manage blood sugar more effectively. It can be taken alone, and in cases where previous diabetes medications have been used or monotherapy is insufficient, it can be administered in combination with other medications, including metformin. Additionally, when various combinations of medications such as sulfonylureas, thiazolidinediones, and insulin do not achieve adequate blood sugar control, this medication can be added to improve blood sugar regulation. Overall, this medication is effective in enhancing blood sugar control in various therapeutic settings.
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. It may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Since dose adjustment is required according to renal function, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. The dose for patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2) is 50 mg once daily. 4. The dose for patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2) is 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.
This medication may rarely cause serious allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur after taking the medication, it should be stopped immediately, and medical attention should be sought. During the use of this medication, acute pancreatitis may occur, marked by symptoms such as abdominal pain, nausea, or vomiting; if these symptoms arise, it is crucial to visit a hospital promptly. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor in patients who have had severe allergic reactions to this medication or its components. Patients with impaired kidney function may need dosage adjustments, thus regular renal function tests are advisable, and the medication should be taken according to a doctor's instructions. Cold-like symptoms or headache, dyspepsia, and diarrhea may occur during the use of this medication, and if these symptoms are severe, it is recommended to consult a doctor. Using this medication in conjunction with other hypoglycemic agents or insulin may lead to hypoglycemic symptoms; thus, frequent blood sugar monitoring is necessary, and any hypoglycemic symptoms should be addressed immediately. Severe joint pain or skin conditions such as bullous pemphigoid may occur, and immediate notification to a physician is warranted if such symptoms appear. Pregnant or breastfeeding women are advised not to use this medication, and safety and efficacy in children under 18 years have not been confirmed. Elderly patients may experience decreased renal function, thus regular monitoring of kidney function before and after taking this medication is essential. In case of overdose, standard emergency measures should be taken, and if necessary, blood dialysis can be used to remove the medication, so visit a medical institution immediately. This medication does not have major interactions with other medications, but caution is needed when taking certain medications, so always inform your doctor or pharmacist of all medications being taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air. It is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way will maintain its effectiveness and ensure safe use.
Light orange, round, double convex film-coated tablet
30 tablets - 10 tablets/PTP[x3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Samsung Pharm Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.